Longyun Li

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

Roy S. Herbst, Yan Sun, Wilfried Eberhardt et al. · The Lancet Oncology · 2010 · 417 citations · Full text

Second-line Treatment, Oncology, Metronomic Therapy +10

The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways

Meng Lu, Longyun Li, Shan Lu et al. · Molecular Immunology · 2017 · 302 citations

Acute Lung Injury, Pi3k/akt/mtor Pathways, Inflammatory Lung Disease +16

Intraoperative hypothermia and its clinical outcomes in patients undergoing general anesthesia: National study in China

Jie Yi, Yongjing Lei, Shiyuan Xu et al. · PLoS ONE · 2017 · 164 citations · Full text

Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma

Jing Zhao, Minjiang Chen, Wei Zhong et al. · Clinical Lung Cancer · 2012 · 120 citations

Medicine, Cerebrospinal Fluid, Lung Adenocarcinoma +4

Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients

Xiao Zhao, Rubing Han, Jing Zhao et al. · Respiration · 2012 · 106 citations · Full text